Aerie Pharmaceuticals (AERI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
Sales | 14,456 | 7,302 | 2,423 | 0 | 0 |
Cost of Goods | 377 | 205 | 59 | N/A | N/A |
Gross Profit | 14,079 | 7,097 | 2,364 | N/A | N/A |
Operating Expenses | 66,381 | 68,640 | 58,107 | 40,795 | 60,314 |
Operating Income | -51,925 | -61,338 | -55,684 | -40,795 | -60,314 |
Other Income | 467 | -24,050 | 663 | 96 | -99 |
Pre-tax Income | -51,458 | -85,388 | -55,021 | -40,699 | -60,413 |
Income Tax | N/A | N/A | 3 | N/A | -1,900 |
Net Income Continuous | -51,458 | -85,388 | -55,024 | -40,699 | -58,513 |
Net Income | $-51,458 | $-85,388 | $-55,024 | $-40,699 | $-58,513 |
EPS Basic Total Ops | -1.17 | -1.96 | -1.40 | -1.05 | -1.64 |
EPS Basic Continuous Ops | -1.17 | -1.96 | -1.40 | -1.05 | -1.63 |
EPS Diluted Total Ops | -1.17 | -1.96 | -1.40 | -1.05 | -1.64 |
EPS Diluted Continuous Ops | -1.17 | -1.96 | -1.40 | -1.05 | -1.63 |
EBITDA(a) | $-50,400 | $-60,056 | $-54,868 | $-40,330 | $-59,787 |